Intratumoral activation and enhanced chemotherapeutic effect of oxazaphosphorines following cytochrome P-450 gene transfer: development of a combined chemotherapy/cancer gene therapy strategy

scientific article published on February 1995

Intratumoral activation and enhanced chemotherapeutic effect of oxazaphosphorines following cytochrome P-450 gene transfer: development of a combined chemotherapy/cancer gene therapy strategy is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID7834628

P50authorDavid J. WaxmanQ30506493
P2093author name stringChen L
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectcancer gene therapyQ124350675
gene therapyQ213901
chemotherapyQ974135
P304page(s)581-589
P577publication date1995-02-01
P1433published inCancer ResearchQ326097
P1476titleIntratumoral activation and enhanced chemotherapeutic effect of oxazaphosphorines following cytochrome P-450 gene transfer: development of a combined chemotherapy/cancer gene therapy strategy
P478volume55

Reverse relations

cites work (P2860)
Q26860729Adenoviral vectors for prodrug activation-based gene therapy for cancer
Q35768314Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter
Q32117273Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites
Q41349050Direct cell killing by suicide genes
Q30842293Encapsulated cells expressing a chemotherapeutic activating enzyme allow the targeting of subtoxic chemotherapy and are safe and efficacious: data from two clinical trials in pancreatic cancer
Q39713581Enhancement of drug sensitivity and a bystander effect in PC-9 cells transfected with a platelet-derived endothelial cell growth factor thymidine phosphorylase cDNA.
Q37037051Enhancement of intratumoral cyclophosphamide pharmacokinetics and antitumor activity in a P450 2B11-based cancer gene therapy model
Q35118933Gene therapy and targeted toxins for glioma
Q57006162Gene therapy and targeted toxins for glioma
Q33995752HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications
Q41897991Increased cytotoxicity and bystander effect of 5-fluorouracil and 5-deoxy-5-fluorouridine in human colorectal cancer cells transfected with thymidine phosphorylase
Q90645513Kinetics of Cyclophosphamide Metabolism in Humans, Dogs, Cats, and Mice and Relationship to Cytotoxic Activity and Pharmacokinetics
Q33901287Metabolism and pharmacokinetics of oxazaphosphorines
Q34749403Modulation of P450-dependent ifosfamide pharmacokinetics: a better understanding of drug activation in vivo
Q42137028Mouse mammary tumor virus promoter-containing retroviral promoter conversion vectors for gene-directed enzyme prodrug therapy are functional in vitro and in vivo
Q39916257Potentiation of methoxymorpholinyl doxorubicin antitumor activity by P450 3A4 gene transfer
Q24792836Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy)
Q73429925Prodrugs in Cancer Chemotherapy
Q35972548Self-assembled mPEG-PCL-g-PEI micelles for simultaneous codelivery of chemotherapeutic drugs and DNA: synthesis and characterization in vitro
Q41030442The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions

Search more.